Effect of INitial Combination Therapy With GEmigliptin and Metformin on Microbiota Change and Glycemic Control in patientS With Type 2 DIabetes aNd ObEsity (INTESTINE Study)
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Gemigliptin/glimepiride (Primary) ; Glimepiride/metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms INTESTINE
- 05 Oct 2017 Planned End Date changed from 1 Mar 2018 to 1 Dec 2018.
- 05 Oct 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.
- 10 Jun 2017 Biomarkers information updated